Treatment
L-Dopa clinical trials
We’re tracking 5 recruiting studies that include L-Dopa, each written for real people, not researchers, below.
Recruiting studies
- NCT07614126Recruiting
L-dopa Treatment for Children With CTNNB1 Gene Disorder
This study tests whether L-dopa medication can help children with a rare genetic disorder (caused by changes in the CTNNB1 gene) that causes involuntary muscle movements called dystonia. Researchers want to see if this medicine can reduce these movements and improve daily function.
Montpellier, HéraultAges 1–15 - NCT05909267Recruiting
Testing dopamine-targeted treatment for depression and body inflammation
This study looks at how changing dopamine signaling may affect motivation and movement in people with major depression, and it also involves healthy volunteers. It may help researchers understand whether dopamine changes can improve symptoms and how inflammation may relate to brain function.
SteglitzAges 18–65 - NCT06626152RecruitingPhase 2
L-DOPA challenge test for depression in older adults
This study tests whether a medication called L-DOPA (used for Parkinson's disease) can help predict how well older adults with depression will respond to treatment. You will take a single dose of L-DOPA and then do simple tasks to measure your mood and thinking.
Vancouver, British ColumbiaAges 60 years+ - NCT07370532RecruitingPhase 2
Etoricoxib for Parkinson's disease
This study tests if etoricoxib, an anti-inflammatory drug, can help people with Parkinson's disease. You may join if you have a confirmed diagnosis and are not using other anti-inflammatory drugs.
Al MansurahAges 50–70 - NCT00439049Recruiting
Screening for substance-abuse treatment readiness
This study helps check whether people who want help for substance use (like cocaine, opiates, or alcohol) are ready to start a treatment program. It may improve how treatment is matched and started, though you must be able to commit for several months.
Houston, TexasAges 18–60
What L-Dopa is being studied for
Conditions with recruiting L-Dopa studies.
Common questions
- Are there clinical trials studying L-Dopa?
- Yes. Clin2 currently lists 5 recruiting studies that include L-Dopa, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a L-Dopa trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is L-Dopa an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether L-Dopa or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.